These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8373710)

  • 1. The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.
    Tingle MD; Park BK
    Br J Clin Pharmacol; 1993 Jul; 36(1):31-8. PubMed ID: 8373710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preincubation with cimetidine on the N-hydroxylation of dapsone by human liver microsomes.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1991 Jul; 32(1):120-3. PubMed ID: 1888631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.
    Tingle MD; Coleman MD; Park BK
    Br J Clin Pharmacol; 1990 Dec; 30(6):829-38. PubMed ID: 2288829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadal influence on the metabolism and haematological toxicity of dapsone in the rat.
    Coleman MD; Tingle MD; Winn MJ; Park BK
    J Pharm Pharmacol; 1990 Oct; 42(10):698-703. PubMed ID: 1982141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the haematological toxicity of structural analogues of dapsone in-vivo and in-vitro.
    Coleman MD; Tingle MD; Hussain F; Storr RC; Park BK
    J Pharm Pharmacol; 1991 Nov; 43(11):779-84. PubMed ID: 1686906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the toxicity of analogues of dapsone in-vitro using rat, human and heterologously expressed metabolizing systems.
    Coleman MD; Smith SN; Kelly DE; Kelly SL; Seydel JK
    J Pharm Pharmacol; 1996 Sep; 48(9):945-50. PubMed ID: 8910859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro. IV: Implications for the development of agranulocytosis.
    Coleman MD; Simpson J; Jacobus DP
    Biochem Pharmacol; 1994 Oct; 48(7):1349-54. PubMed ID: 7945432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the haemotoxicity of dapsone: the importance of the sulphonyl group.
    Mahmud R; Tingle MD; Maggs JL; Cronin MT; Dearden JC; Park BK
    Toxicology; 1997 Feb; 117(1):1-11. PubMed ID: 9020194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro--II. Movement of dapsone across a semipermeable membrane into erythrocytes and plasma.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Oct; 46(8):1363-8. PubMed ID: 8240384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation of dapsone to a cytotoxic metabolite: in vitro use of a novel two compartment system which contains human tissues.
    Riley RJ; Roberts P; Coleman MD; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1990 Sep; 30(3):417-26. PubMed ID: 2223420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the metabolism and toxicity of dapsone in rat, mouse and man.
    Tingle MD; Mahmud R; Maggs JL; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 1997 Nov; 283(2):817-23. PubMed ID: 9353403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
    Vage C; Saab N; Woster PM; Svensson CK
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro.
    Coleman MD; Jacobus DP
    Biochem Pharmacol; 1993 Mar; 45(5):1027-33. PubMed ID: 8461032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.
    Reilly TP; Bellevue FH; Woster PM; Svensson CK
    Biochem Pharmacol; 1998 Mar; 55(6):803-10. PubMed ID: 9586952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450-dependent toxicity of dapsone in human erythrocytes.
    Ganesan S; Sahu R; Walker LA; Tekwani BL
    J Appl Toxicol; 2010 Apr; 30(3):271-5. PubMed ID: 19998329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].
    Skakun NP
    Klin Med (Mosk); 1982 Jan; 60(1):24-7. PubMed ID: 6122757
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes.
    Coleman MD; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1989 Oct; 28(4):389-95. PubMed ID: 2590600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.
    Bian Y; Kim K; An GJ; Ngo T; Bae ON; Lim KM; Chung JH
    Toxicol Sci; 2019 Dec; 172(2):435-444. PubMed ID: 31428780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.